Table 1.
Patient group characteristics
| Variable N = 45,809 |
Predominantly in person 41,798 (74.7) | Mixed 6,067 (10.9) |
Predominantly telemedicine 8,059 (14.4) | d |
|---|---|---|---|---|
| Age | ||||
| 15–24 | 7,069 (69.0) | 1,405 (13.7) | 1,770 (17.3) | 9.1 |
| 25–34 | 13,762 (72.4) | 2,372 (12.5) | 2,872 (15.11) | |
| 35–44 | 9,131 (75.5) | 1,252 (10.4) | 1,712 (14.2) | |
| 45–54 | 7,790 (79.5 | 780 (8.0) | 1,230 (12.6) | |
| 54–65 | 3,057 (83.0) | 230 (6.2) | 398 (10.8) | |
| 65+ | 989 (90.4) | 28 (2.6) | 77 (7.0) | |
| Sex | ||||
| Male | 27,729 (76.5) | 3,783 (10.4) | 4,718 (13.0) | 2.0 |
| Female | 14,069 (71.44) | 2,284 (11.6) | 3,341 (17.0) | |
| Geography | ||||
| Southern urban | 35,242 (81.8) | 3,878 (9.0) | 3,979 (9.23) | 0.6 |
| Northern rural | 869 (30.7) | 494 (17.44) | 1,470 (51.9) | |
| Northern urban | 2,506 (47.3) | 1,006 (19.0) | 1,782 (33.7) | |
| Southern rural | 3,181 (67.7) | 689 (14.7) | 868 (17.6) | |
| Income | ||||
| 1 (lowest) | 13,604 (71.2) | 2,286 (12.0) | 3,205 (16.8) | 3.9 |
| 2 | 9,540 (76.3) | 1,284 (10.3) | 1,675 (13.4) | |
| 3 | 7,535 (75.6) | 1,078 (10.8) | 1,359 (13.6) | |
| 4 | 6,303 (77.9) | 812 (10.0) | 977 (12.1) | |
| 5 | 4,816 (76.9) | 607 (9.7) | 843 (13.5) | |
| Deep tissue infections | 1,316 (3.2)) | 143 (2.4) | 217 (2.7) | 0.3 |
| HIV status | 306 (0.7) | 38 (0.6) | 67 (0.8) | 0.2 |
| Mean days on methadone (SD)** | 376.8 (471.6) | 385.6 (454.7) | 444.9 (490.3) | 16.4 |
| Mean days on buprenorphine (SD)** | 56.6 (169.5) | 40.9 (136.7) | 29.0 (107.3) | 16.3 |
d, standardized difference; SD, standard deviation. ** Subgroup analysis, n = 28,000.